Rapport Therapeutics, Inc. (RAPP)

Rapport Therapeutics Statistics

Total Valuation

RAPP has a market cap or net worth of $1.40 billion. The enterprise value is $896.75 million.

Market Cap	1.40B
Enterprise Value	896.75M

Important Dates

The last earnings date was Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

RAPP has 47.66 million shares outstanding. The number of shares has increased by 190.80% in one year.

Current Share Class	47.66M
Shares Outstanding	47.66M
Shares Change (YoY)	+190.80%
Shares Change (QoQ)	+7.02%
Owned by Insiders (%)	4.65%
Owned by Institutions (%)	72.81%
Float	30.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.67
P/TBV Ratio	2.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 36.37, with a Debt / Equity ratio of 0.02.

Current Ratio	36.37
Quick Ratio	35.84
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -23.41% and return on invested capital (ROIC) is -16.23%.

Return on Equity (ROE)	-23.41%
Return on Assets (ROA)	-15.89%
Return on Invested Capital (ROIC)	-16.23%
Return on Capital Employed (ROCE)	-21.13%
Revenue Per Employee	n/a
Profits Per Employee	-$1.42M
Employee Count	69
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +36.18% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+36.18%
50-Day Moving Average	26.89
200-Day Moving Average	16.65
Relative Strength Index (RSI)	60.35
Average Volume (20 Days)	371,575

Short Selling Information

The latest short interest is 2.00 million, so 4.20% of the outstanding shares have been sold short.

Short Interest	2.00M
Short Previous Month	1.93M
Short % of Shares Out	4.20%
Short % of Float	6.59%
Short Ratio (days to cover)	5.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-110.11M
Pretax Income	-97.70M
Net Income	-97.70M
EBITDA	-109.10M
EBIT	-110.11M
Earnings Per Share (EPS)	-$2.72

Balance Sheet

The company has $513.03 million in cash and $11.87 million in debt, giving a net cash position of $501.15 million or $10.51 per share.

Cash & Cash Equivalents	513.03M
Total Debt	11.87M
Net Cash	501.15M
Net Cash Per Share	$10.51
Equity (Book Value)	511.62M
Book Value Per Share	10.74
Working Capital	506.34M

Cash Flow

In the last 12 months, operating cash flow was -$77.22 million and capital expenditures -$673,000, giving a free cash flow of -$77.89 million.

Operating Cash Flow	-77.22M
Capital Expenditures	-673,000
Free Cash Flow	-77.89M
FCF Per Share	-$1.63

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RAPP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-190.80%
Shareholder Yield	-190.80%
Earnings Yield	-6.99%
FCF Yield	-5.57%

Analyst Forecast

The average price target for RAPP is $46.60, which is 58.88% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$46.60
Price Target Difference	58.88%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-7.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1